CanSino Biologics Inc. (6185.HK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for CanSino Biologics Inc., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | 285.14x |
| P/B Ratio | 1.60x |
| P/S Ratio | 7.70x |
| Profitability | |
| Gross Margin | 66.1% |
| Operating Margin | -11.0% |
| Net Margin | 2.6% |
| EBITDA Margin | 5.9% |
| Liquidity | |
| Current Ratio | 3.55x |
| Quick Ratio | 3.23x |
| Leverage | |
| Debt/Equity | 0.26x |
YoY = year-over-year change. Source: FMP..